SCHEMBL6482897

SCHEMBL6482897

CC(C)CC[C@H](NC(=O)N1CCOCC1)C(=O)NC1C(=O)COC1CCN(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 17/20 0.45
CTSL P07711 1/20 0.37
CTSK P43235 1/20 0.37
PKM P14618 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CAPN1 P07384 1/20 0.35
PSMB11 A5LHX3 1/20 0.34
PSMA7 O14818 1/20 0.34
PSMB1 P20618 1/20 0.34
PSMA1 P25786 1/20 0.34
PSMA2 P25787 1/20 0.34
PSMA3 P25788 1/20 0.34
PSMA4 P25789 1/20 0.34
PSMB8 P28062 1/20 0.34
PSMB9 P28065 1/20 0.34
PSMA5 P28066 1/20 0.34
PSMB4 P28070 1/20 0.34
PSMB6 P28072 1/20 0.34
PSMB5 P28074 1/20 0.34
PSMB10 P40306 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6487933 0.93 CTSS (0.38) CTSSCTSLCTSKPKMSMN1; SMN2
SCHEMBL6475447 0.89 CTSS (0.48) CTSSCTSLCTSKPKMSMN1; SMN2
SCHEMBL6475996 0.88 CTSS (0.41) CTSSPKMSMN1; SMN2CAPN1PSMB11
SCHEMBL6477041 0.87 CTSS (0.47) CTSSCTSLCTSKPKMSMN1; SMN2
SCHEMBL6476643 0.87 CTSS (0.39) CTSSCTSLCTSKPKMSMN1; SMN2
SCHEMBL6592458 0.87 CTSS (0.33) CTSSCTSLCTSK
SCHEMBL6474920 0.85 CTSS (0.41) CTSSCTSLCTSKCAPN1
SCHEMBL6486213 0.84 CTSS (0.45) CTSSCTSLCTSKPKMSMN1; SMN2
SCHEMBL6476393 0.84 CTSS (0.49) CTSSCTSLCTSKPKMSMN1; SMN2
SCHEMBL6476369 0.81 CTSS (0.43) CTSSCTSLCTSKPSMB11PSMA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050020588-A1 Cysteine protease inhibitors PEPTIMMUNE, INC. 2005-01-27 US claimed
US-20050020588-A1 Cysteine protease inhibitors PEPTIMMUNE, INC. 2005-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050020588-A1 Cysteine protease inhibitors CTSS, CTSE, CTSV CTSS 1/4885CTSL 11/4885CTSK 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.